tubocurarine

Trade name: curare

Small moleculeapproved

Approved

Feb 20, 1945

Tubocurarine, a naturally occurring alkaloid, is used to treat smoking withdrawl syndrom. Tubocurarine, the chief alkaloid in tobacco products, binds stereo-selectively to nicotinic-cholinergic receptors at the autonomic ganglia, in the adrenal medulla, at neuromuscular junctions, and in the brain. Two types of central nervous system effects are believed to be the basis of Tubocurarine's positively reinforcing properties. A stimulating effect is exerted mainly in the cortex via the locus ceruleus and a reward effect is exerted in the limbic system. At low doses the stimulant effects predominate while at high doses the reward effects predominate. Intermittent intravenous administration of Tubocurarine activates neurohormonal pathways, releasing acetylcholine, norepinephrine, dopamine, serotonin, vasopressin, beta-endorphin, growth hormone, and ACTH. Tubocurarine competes with acetylcholine for post-synaptic nicotinic NM receptors and blocks them. — NCATS

Clinical trial activity

0 trials · 0 clinical orgs · 5 marketing orgs

Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0

Timeline

1940s

  1. Feb 20, 1945

    Bristol-Myers — Earliest FDA Approval

  2. Feb 20, 1945

    Bristol-Myers Squibb — NDA Secondary Org

  3. Feb 20, 1945

    Bristol-Myers — NDA Organization

  4. Jan 30, 1947

    Hospira — NDA Secondary Org

  5. Nov 28, 1947

    Eli Lilly — Marketing Organization

  6. Nov 28, 1947

    Eli Lilly — NDA Secondary Org

Indications

Mechanism of action

Approval history

  • approvedPriority reviewFeb 20, 1945

Chemistry & pharmacology

Loading structure…

SMILES

COc1cc2c3cc1Oc1cc(ccc1O)C[C@@H]1c4c(cc(OC)c(O)c4Oc4ccc(cc4)C[C@@H]3N(C)CC2)CC[N+]1(C)C.Cl.O.O.O.O.O.[Cl-]
Mol. weight
771.73 g/mol
Lipinski Ro5
2 violation(s)
Rule of 3
No
Chirality
Single Stereoisomer
Inorganic
No
Polymer
No
Delivery
Parenteral
Availability
Discontinued

Oral

No

Parenteral

Yes

Topical

No

Sources

Also known as

  • 7',12'-dihydroxy-6,6'-dimethoxy-2,2',2'-trimethyltubocuraranium
  • 7',12'-dihydroxy-6,6'-dimethoxy-2,2',2'-trimethyltubocuraranium
  • dextrotubocurarine chloride
  • dtc
  • dtc
  • d-tubocurarine
  • d-tubocurarine
  • d-tubocurarine
  • jexin
  • jexin
  • tubarine
  • tubarine
  • tubocurarin
  • tubocurarin
  • tubocurarine
  • tubocurarine
  • tubocurarine
  • tubocurarine
  • tubocurarine
  • tubocurarine
  • tubocurarine
  • tubocurarine
  • tubocurarine
  • (+)-tubocurarine
  • (+)-tubocurarine
  • (+)-tubocurarine chloride
  • tubocurarine chloride
  • tubocurarine chloride
  • tubocurarine chloride
  • tubocurarine chloride
  • (+)-tubocurarine dichloride
  • tubocurarine hcl
  • tubocurarine hydrochloride

Organizations

Marketing (6)

OrganizationOrg typeRelationshipDate
Athenex, Inc.For profitMKTG
Bristol-MyersFor profitNDAFeb 20, 1945
Bristol-Myers SquibbFor profitNDA2Feb 20, 1945
Eli LillyFor profitMKTGNov 28, 1947
Eli LillyFor profitNDA2Nov 28, 1947
HospiraFor profitNDA2Jan 30, 1947